Armetheon Completes $7.0 Million Series A Financing

Menlo Park, CA – August 28, 2014 — Armetheon, Inc. (www.armetheon.com), a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing....